Stent News and Research

RSS

A stent is a small mesh tube that’s used to treat narrowed or weakened arteries in the body.

You may have a stent placed in an artery as part of a procedure called angioplasty (AN-jee-oh-plas-tee). Angioplasty can restore blood flow through narrowed or blocked arteries. Stents help prevent arteries from becoming narrowed or blocked again in the months or years after treatment with angioplasty. You may also have a stent placed in a weakened artery to improve blood flow and to help prevent the artery from bursting.

Stents are usually made of metal mesh, but sometimes they’re made of fabric. Fabric stents, also called stent grafts, are used in larger arteries. Some stents are coated with medicines that are slowly and continuously released into the artery. These medicines help prevent the artery from becoming blocked again.

Multi-center study compares clinical performance of AAA procedures in virtual environment

University Hospitals (UH) Case Medical Center and Simbionix recently launched a multi-center, randomized study comparing the clinical performance of abdominal aortic aneurysm (AAA) procedures with and without prior rehearsal in a virtual environment for physicians.

13 Oct 2014

Abbott announces initiation of ABSORB IV heart stent clinical trial

Abbott announced today the start of the ABSORB IV clinical trial, which will test whether its Absorb Bioresorbable Vascular Scaffold (BVS) is more cost-effective and offers a higher quality of life than a best-in-class, permanent, metallic drug eluting stent.

16 Sep 2014

Study shows 1 in 10 patients may not need surgery following heart attack

Researchers from the Golden Jubilee National Hospital and the University of Glasgow have reported a study that shows one in ten patients may not need cardiac intervention following a heart attack and in those that do need stents, the procedure can be targeted more effectively.

4 Sep 2014

Ambulance administration of antiplatelet medication may help heart attack patients

Ambulance administration of the antiplatelet medication ticagrelor to patients with a type of heart attack known as ST segment elevation myocardial infarction (STEMI) is not better than hospital administration, in terms of improving blood flow in blocked arteries before a revascularisation procedure, according to a new study presented at ESC Congress 2014 today.

2 Sep 2014

ESC Guidelines on diagnosis and treatment of aortic diseases published in European Heart Journal

The first comprehensive ESC Guidelines on aortic diseases are published today. They are presented at ESC Congress 2014 by Task Force Chairpersons Professor Raimund Erbel (Germany) and Professor Victor Aboyans (France).

30 Aug 2014

Janssen, Bayer announce expansion of EXPLORER global cardiovascular research program for XARELTO

Janssen Research & Development, LLC and its development partner, Bayer HealthCare, announced today the expansion of the EXPLORER global cardiovascular research program for XARELTO (rivaroxaban) to include additional high-risk patient populations.

29 Aug 2014

Study explores the effectiveness of stents in treating vein obstructions

Jobst Vascular Institute is conducting pioneering research that looks at using stents to treat blocked veins. For years, stents - small mesh tubes - have been used to treat narrowed or blocked arteries; however none are specifically designed for use in veins.

20 Aug 2014

Researchers compare benefits of bivalirudin and heparin for patients undergoing coronary stenting

Bivalirudin and heparin are two anticoagulant options for patients undergoing coronary stenting for ischemic heart disease. Bivalirudin, a newer anticoagulant, has been touted as being as effective as generic heparin, but with nearly half the rate of bleeding.

18 Aug 2014

Research leads to optimal design of alternative to open-heart surgery

University of Houston (UH) professor Suncica "Sunny" Canic is a mathematician, not a medical doctor, but her research could save the lives of heart patients.

13 Aug 2014

Codman Neuro introduces new ENVOY Guiding Catheters for neurovascular procedures

Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, announced the launch of the ENVOY DA XB Distal Access Guiding Catheter and the 7F ENVOY Guiding Catheter for neurovascular procedures.

31 Jul 2014

Drug-eluting peripheral stent from Cook Medical selected as a top 10 game-changing health technology for 2014

As announced at the 2014 Canadian Agency for Drugs and Technologies in Health (CADTH) symposium, the Canadian Network for Environmental Scanning in Health (CNESH) has selected Cook Medical’s Zilver® PTX® drug-eluting peripheral stent as a top 10 game-changing health technology for 2014. The CNESH top 10 list is designed to encourage the adoption and use of effective, safe health technologies in Canada.

From COOK MEDICAL INC. 24 Jul 2014

Study: History of stroke associated with increased risk of adverse events after elective noncardiac surgery

In an analysis that included more than 480,000 patients who underwent elective noncardiac surgery, a history of stroke was associated with an increased risk of major adverse cardiovascular events and death, particularly if time elapsed between stroke and surgery was less than 9 months, according to a study in the July 16 issue of JAMA.

16 Jul 2014

Radial artery catheterization much safer for women

Instead of going through the groin during heart catheterizations, physicians can now insert the catheter through a patient's wrist, a less traumatic and safer option for some patients — especially women.

14 Jul 2014

Boston Scientific gains CE Mark, begins European commercial launch of 25 mm Lotus TAVI System

Boston Scientific Corporation has received CE Mark and begun the European commercial launch of its new 25 mm Lotus Transcatheter Aortic Valve Implantation (TAVI) System, complementing the currently available 23 mm and 27 mm valve sizes.

14 Jul 2014

VENITI’s IDE receives FDA approval for VENITI VICI Venous Stent System

VENITI, Inc., a company dedicated to providing innovative technology for the treatment of venous disease, announced that it has received approval from the United States Food and Drug Administration (FDA) for an Investigational Device Exemption (IDE) to begin the VIRTUS trial of the VENITI VICI Venous Stent System.

14 Jul 2014

Study: Minimally invasive aortic repair procedure safer for patients

Researchers at the University of California, San Diego School of Medicine have documented the safety benefits of aortic stent grafts inserted during minimally invasive surgery to repair abdominal aortic aneurysms - weaknesses in the body's largest artery that can rupture, causing potentially lethal internal bleeding.

10 Jul 2014

Cordis launches SABER Catheter for treatment of patients with Peripheral Arterial Disease

Cordis Corporation announced today the launch of its SABER PTA Dilatation Catheter ("SABER Catheter") for the treatment of patients with Peripheral Arterial Disease (PAD).

1 Jul 2014

Lombard Medical exhibits Aorfix system at Critical Issues in Aortic Endografting symposium

Lombard Medical, Inc, a medical device company focused on Endovascular Aortic Repair (EVAR) of abdominal aortic aneurysms (AAA), exhibited its Aorfix Endovascular stent graft system at the 18th international experts' symposium, Critical Issues in Aortic Endografting, in Malmö, Sweden on June 27-28, 2014.

30 Jun 2014

Lombard Medical showcases Aorfix Endovascular Stent Graft at SVS Annual Meeting

Lombard Medical, Inc., a medical device company focused on Endovascular Aortic Repair (EVAR) of abdominal aortic aneurysms (AAA), showcased its Aorfix Endovascular Stent Graft at the 2014 Society for Vascular Surgery Annual Meeting in Boston, June 5-7.

6 Jun 2014

Cook Medical introduces Zilver PTX Drug-Eluting Peripheral Stent in Canada

Cook Medical launched its Zilver PTX Drug-Eluting Peripheral Stent in Canada at the Canadian Interventional Radiology Association (CIRA) meeting in Montreal, Canada. It's the first drug-coated stent in Canada indicated to treat peripheral arterial disease (PAD) in the superficial femoral artery (SFA).

From COOK MEDICAL INC. 5 Jun 2014

Stent News and Research

Further Reading

Multi-center study compares clinical performance of AAA procedures in virtual environment

Abbott announces initiation of ABSORB IV heart stent clinical trial

Study shows 1 in 10 patients may not need surgery following heart attack

Ambulance administration of antiplatelet medication may help heart attack patients

ESC Guidelines on diagnosis and treatment of aortic diseases published in European Heart Journal

Janssen, Bayer announce expansion of EXPLORER global cardiovascular research program for XARELTO

Study explores the effectiveness of stents in treating vein obstructions

Researchers compare benefits of bivalirudin and heparin for patients undergoing coronary stenting

Research leads to optimal design of alternative to open-heart surgery

Codman Neuro introduces new ENVOY Guiding Catheters for neurovascular procedures

Drug-eluting peripheral stent from Cook Medical selected as a top 10 game-changing health technology for 2014

Study: History of stroke associated with increased risk of adverse events after elective noncardiac surgery

Radial artery catheterization much safer for women

Boston Scientific gains CE Mark, begins European commercial launch of 25 mm Lotus TAVI System

VENITI’s IDE receives FDA approval for VENITI VICI Venous Stent System

Study: Minimally invasive aortic repair procedure safer for patients

Cordis launches SABER Catheter for treatment of patients with Peripheral Arterial Disease

Lombard Medical exhibits Aorfix system at Critical Issues in Aortic Endografting symposium

Lombard Medical showcases Aorfix Endovascular Stent Graft at SVS Annual Meeting

Cook Medical introduces Zilver PTX Drug-Eluting Peripheral Stent in Canada

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News